Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — Q3 2025 Earnings Presentation
15 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Oct 30, 2025
Slide 1: 9M Conference Call
9M Conference Call Drägerwerk AG & Co. KGaA October 29, 2025, Lübeck
Slide 2: Disclaimer
Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future
Slide 3: Agenda
Agenda — 01 Dräger Business Highlights 02 Financials 9M 2025 03 Outlook FY 2025 Drägerwerk AG & Co. KGaA 3
Slide 4: Dräger Business Highlights
01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4
Slide 5: 9M 2025: Outlook more optimistic due to strong business performance
9M 2025 Outlook more optimistic due to Higher net sales, slightly strong business performance lower EBIT, better cash flow Highlights High demand for Technology for Life: highest order intake since record 9M 2020; growth driven by both divisions and all regions; major order from Mexico Net sales EBI
Slide 6: Financials 9M 2025
02 Financials 9M 2025 Drägerwerk AG & Co. KGaA 6
Slide 7: Business development Group
Business development Group Order entry 9M 2024 9M 2025 Change — (€ million) (fx-adj.) Germany 586.7 587.8 +0.2 Net sales (€ million) EMEA 923.6 1,030.4 +11.5 +10.1% +3.7% Americas 521.8 591.6 +19.1 fx-adj fx-adj +7.6% +2.1% APAC 388.5 384.4 +2.9 nominal nominal 2,295 2,344 Total 2,420.5 2,594.1 +9.0
Slide 8: Business development Medical
Business development Medical Order entry 9M 2024 9M 2025 Change — (€ million) (fx-adj.) Germany 304.9 318.3 +4.4 Net sales (€ million) EMEA 472.2 527.0 +11.6 +10.2% +4.7% Americas 352.2 408.6 +22.3 fx-adj fx-adj +7.3% +2.9% APAC 239.2 241.6 +4.9 nominal nominal 1,285 1,322 Total 1,368.5 1,495.5 +11.
Slide 9: Business development Safety
Business development Safety Order entry 9M 2024 9M 2025 Change — (€ million) (fx-adj.) Germany 281.8 269.4 -4.4 Net sales (€ million) EMEA 451.4 503.4 +11.5 +9.9% +2.4% Americas 169.6 183.0 +12.5 fx-adj fx-adj +7.9% +1.1% APAC 149.3 142.7 -0.3 nominal nominal 1.010 1.021 Total 1,052.1 1,098.6 +5.7 3
Slide 10: Key figures
Key figures 9M 2025 9M 2024 Change € million € million % Cashflow (from operating activities) 92.6 57.2 +61.8 Investments 93.5 78.9 +18.5 Cash and cash equivalents1 188.3 179.8 +4.7 Net financial debt1 221.9 230.6 -3.8 Net financial debt1 / EBITDA2 0.7 0.7 Capital employed 1 1,589.0 1,550.7 +2.5 ROC
Slide 11: Outlook FY 2025
03 Outlook FY 2025 Drägerwerk AG & Co. KGaA 11
Slide 12: Outlook
Outlook Results achieved in Forecast for Current forecast for fiscal year 2024 fiscal year 2025 fiscal year 2025 Net sales (net of currency effects) 0.5% 1.0 to 5.0% 3.0 to 5.0% EBIT margin 5.8% 3.5 to 6.5% 4.5 to 6.5% Dräger Value Added (DVA) EUR 54.3 million EUR -30 to 80 million EUR 10 to 80 mill
Slide 13: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA 13
Slide 14: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 31, 2025 Annual Report 2024 Conference call April 30, 2025 Report for the first three months 2025 Conference
Slide 15: Thank you
Thank you Thomas Fischler Nikolaus Hammerschmidt Head of Treasury & Investor Relations Investor Relations Manager Moislinger Alle 53-55 Moislinger Alle 53-55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel. +49 451 882 2685 Tel. +49 451 882 8903 Mail: thomas.fischler@draeger.com Mail: nikolaus.hamme
Drägerwerk AG & Co. KGaA — Q3 2025 Earnings Presentation on 6ix